Diversion Control Homepage Diversion Control Homepage Privacy Policy Contact Us What's New Hot Items Site Map Search Diversion SiteDEA Diversion Control Program Logo and Banner

Federal Register Notices > Notices of Application - 2003 > AccuStandard Inc.

Notices of Application - 2003

[Federal Register: June 19, 2003 (Volume 68, Number 118)]
[Notices]
[Page 36841-36843]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr19jn03-84]

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled Substances; Notice of Application

Pursuant to section 1301.33(a) of title 21 of the Code of Federal Regulations (CFR), this is notice that on February 19, 2003, AccuStandard Inc., 125 Market Street, New Haven, Connecticut 06513, made application by renewal and on May 7, 2003, by letter, to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer of the basic classes of Schedule I and II controlled substances listed below:

Drug

Schedule
Cathinone (1235) I
Methcathinone (1237) I
N-Ethylamphetamine (1475) I
N,N-Dimethylamphetamine (1480) I
Fenethylline (1503) I
Aminorex (1585) I
4-Methylaminorex (cis isomer) I
Gamma hydroxybutyric acid (2010) I
Methaqualone (2565) I
Mecloqualone (2572) I
Alpha-Ethyltryptamine (7249) I
Ibogaine (7260) I
Lysergic acid diethylamide (7315) I
Tetrahydrocannabinols (7370) I
Mescaline (7381) I
3,4,5-Trimethoxyamphetamine (7390) I
4-Bromo-2,5-dimethoxyamphetamine (7391) I
4-Bromo-2,5-dimethoxyamphetamine (7392) I
4-Methyl-2,5-dimethoxyamphetamine (7395) I
2,5-Dimethoxyamphetamine (7396) I
2,5-Dimethoxy-4-ethylamphetamine (7399) I
3,4-Methylenedioxyamphetamine (7400) I
5-Methoxy-3,4-methylenedioxyamphetamine (7401) I
N-Hydroxy-3,4-methylenedioxyamphetamine (7402) I
3,4-Methylenedioxy-N-ethylamphetamine (7404) I
3,4-Methylenedioxymethamphetamine (7405) I
4-Methoxyamphetamine (7411) I
Bufotenine (7433) I
Diethyltryptamine (7434) I
Dimethyltryptamine (7435) I
Psilocybin (7437) I
Psilocyn (7438) I
N-Ethyl-1-phenylcyclohexylamine (7455) I
1-(1-Phenylcyclohexyl) pyrrolidine (PCPY) (7458) I
1-[1-(2-Thienyl) cyclohexyl] piperidine (7470) I
1-[1-(2-Thienyl) cyclohexyl] pyrrolidine (TCPY) (7473) I
N-Ethyl-3-piperidyl benzilate (7482) I
N-Methyl-3-Piperidyl benzilate (7484) I
Acetyldihydrocodeine (9051) I
Benzylmorphine (9052) I
Codeine-N-oxide (9053) I
Cyprenorphine (9054) I
Desomorphine (9055) I
Etorphine (except HCL) (9056) I
Codeine methylbromide (9070) I
Dihydromorphine (9145) I
Difenoxin (9168) I
Heroin (9200) I
Hydromorphinol (9301) I
Methyldesorphine (9302) I
Methyldihydromorphine (9304) I
Morphine methylbromide (9305) I
Morphine methylsulfonate (9306) I
Morphine-N-oxide (9307) I
Myrophine (9308) I
   
[[Page 36842]]  
   
Nicocodeine (9309) I
Nicomorphine (9312) I
Normorphine (9313) I
Pholcodine (9314) I
Thebacon (9315) I
Acetorphine (9319) I
Drotebanol (9335) I
Acetylmethadol (9601) I
Allylprodine (9602) I
Alphacetylmethadol except levo-alphacetylmethadol (9603) I
Alphameprodine (9604) I
Alphamethadol (9605) I
Benzethidine (9606) I
Betacetylmethadol (9607) I
Betameprodine (9608) I
Betamethadol (9609) I
Betaprodine (9611) I
Clonitazene (9612) I
Dextromoramide (9613) I
Diampromide (9615) I
Diethylthiambutene (9616) I
Dimenoxadol (9617) I
Dimepheptanol (9618) I
Dimethylthiambutene (9619) I
Dioxaphetyl butyrate (9621) I
Dipipanone (9622) I
Ethylmethylthiambutene (9623) I
Etonitazene (9624) I
Etoxeridine (9625) I
Furethidine (9626) I
Hydroxypethidine (9627) I
Ketobemidone (9628) I
Levomoramide (9629) I
Levophenacylmorphan (9631) I
Morpheridine (9632) I
Noracymethadol (9633) I
Norlevorphanol (9634) I
Normethadone (9635) I
Norpipanone (9636) I
Phenadoxone (9637) I
Phenampromide (9638) I
Phenoperidine (9641) I
Piritramide (9642) I
Proheptazine (9643) I
Properidine (9644) I
Racemoramide (9645) I
Trimeperidine (9646) I
Phenomorphan (9647) I
Propiram (9649) I
1-Methyl-4-phenyl-4-propionoxypiperidine (9661) I
1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine (9663) I
Tilidine (9750) I
Para-Fluorofentanyl (9812) I
3-Methylfentanyl (9813) I
Alpha-Methylfentanyl (9814) I
Acetyl-alpha-methylfentanyl (9815) I
Benzylfentanyl (9818) I
Beta-Hydroxyfentanyl (9830) I
Beta-Hydroxy-3-methylfentanyl (9831) I
Alpha-Methylthiofentanyl (9832) I
3-Methylthiofentanyl (9833) I
Thenylfentanyl (9834) I
Thiofentanyl (9835) I
Amphetamine (1100) II
Methamphetamine (1105) II
Phenmetrazine (1631) II
Methylphenidate (1724) II
Amobarbital (2125) II
Pentobarbital (2270) II
Secobarbital (2315) II
Glutethimide (2550) II
Nabilone (7379) II
1-Phenylcylohexylamine (7460) II
Phencyclidine (7471) II
   
[[Page 36843]]  
   
Phenylacetone (8501) II
1-Piperidinocyclohexanecarbonitrile (8603) II
Alphaprodine (9010) II
Anileridine (9020) II
Cocaine (9041) II
Codeine (9050) II
Diprenorphine (9058) II
Etorphine HCL (9059) II
Dihydrocodeine (9120) II
Oxycodone (9143) II
Hydromorphone (9150) II
Diphenoxylate (9170) II
Benzoylecgonine (9180) II
Ecgonine (9180) II
Ethylmorphine (9190) II
Hydrocodone (9193) II
Levomethorphan (9210) II
Levorphanol (9220) II
Isomethadone (9226) II
Meperidine (9230) II
Meperidine intermediate-A (9232) II
Meperidine intermediate-B (9233) II
Meperidine intermediate-C (9234) II
Metazocine (9240) II
Methadone (9250) II
Methadone intermediate (9254) II
Metopon (9260) II
Morphine (9300) II
Thebaine (9333) II
Dihydroetorphine (9334) II
Opium, raw (9600) II
Opium tincture (9630) II
Opium powdered (9639) II
Levo-alphacetylmethadol (9648) II
Oxymorphone (9652) II
Phenazocine (9715) II
Piminodine (9730) II
Racemethorphan (9732) II
Racemorphan (9733) II
Alfentanil (9737) II
Remifentanil (9739) II
Sufentanil (9740) II
Carfentanil (9743) II
Bezitramide (9800) II
Fentalyl (9801) II
Moramide-intermediate (9802) II

The firm plans to manufacture small quantities of bulk material for use in reference standards.

Any other such applicant and any person who is presently registered with DEA to manufacture such substances may file comments or objections to the issuance of the proposed registration.

Any such comments or objections may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, United States Department of Justice, Washington, DC 20537, Attention: DEA Federal Register Representative (CCD) and must be filed no later than August 18, 2003.

Dated: June 6, 2003.

Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.

[FR Doc. 03-15534 Filed 6-18-03; 8:45 am]
BILLING CODE 4410-09-M

NOTICE: This is an unofficial version. An official version of these publications may be obtained directly from the Government Printing Office (GPO).

Back to Top

Registration Support  
Toll Free Number: 1-800-882-9539
ARCOS | Career Opportunities | Chemical Program | Controlled Substance Schedules | Drugs and Chemicals of Concern  
 Electronic Commerce Initiatives |  | Federal Register Notices | Import Export | Links | Meetings and Events | NFLIS
 Offices & Directories | On-Line Forms & Applications | Program Description |  Publications | Questions & Answers | Quotas  
  Reports Required by 21 CFR | Title 21 Regulations & Codified CSA
   Contact Us | Home | Hot Items | Site Map | Search | What's New